December 14, 2021 — Canon Medical announced the launch of Altivity, a new AI innovation brand, that consolidates machine learning and deep learning technologies to deliver uncompromised quality and value across the entire care pathway.
Canon Medical has been steadily redefining the role of AI in healthcare, starting with its Advanced intelligent Clear-IQ Engine (AiCE). Initially developed for CT, this denoising deep learning technology was soon deployed across MRI and PET/molecular imaging to help speed up scan times and improve image quality. Next came the launch of Automation Platform and AUTOStroke solution, both of which were designed to enhance clinical confidence and streamline workflows with the power of deep learning technology.
More recently, Canon Medical has transformed the ultrasound space with AI innovations,* that revolutionize clinical workflows. One of the most time-consuming aspects of an ultrasound exam is the care that must be taken to ensure serial measurements are done in a standardized and highly reproducible way. By leveraging the power of AI, Canon Medical has been able to automate these routine tasks to increase clinical productivity and reporting accuracy.
Under the promise of Intelligent healthcare made easy, Altivity enables:
- Informed healthcare - Altivity is here to help enhance clinical confidence with high-quality images and applications that help make informed decisions in real time.
- Fast, tailored care - Altivity has been created with patients in mind, to deliver the fast and accurate results they need for a more personalized treatment approach.
- Efficient workflows - Altivity helps create simple, streamlined AI-driven workflows that optimize resource deployment and ensure your teams have the insights they need to work smarter every day.
Toshio Takiguchi, president and CEO of Canon Medical, said of the launch, “We are passionate about the development of intelligent imaging solutions that reflect the changing medical landscape. With Altivity, we are strengthening our focus to help clinicians leverage their data and transform it into essential insight that improves outcomes for everyone.”
Naoki Sasaki, head of research and development, echoed these sentiments by saying that “Canon Medical’s commitment to continued research and development has resulted in products that are establishing new standards in the area of AI in medicine and healthcare.”
For more information: global.medical.canon/specialties/ai
Additional RSNA21 information can be found here.
* Not available in all regions
March 26, 2026 
